Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05921292 · ClinicalTrials.gov registry record · Early Phase 1
Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies
A Early Phase 1 study, sponsored by Omeza.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 111
- Enrollment target
NCT05921292 is a Early Phase 1 study that has completed, run by Omeza. The registered enrollment target is 111 participants.
The verdict
NCT05921292, a Early Phase 1 study, has completed, sponsored by Omeza.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 111 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate the use of Omeza combination therapy with Standard of Care. The main question it aims to answer is: \- Can Omeza combination therapy with Standard of Care enable chronic wounds to begin a healing trajectory in a 4-week period? Patients will be treated with: * OCM™ Wound Matrix * Omeza combination therapy * Standard of Care
Interventions
- COMBINATION_PRODUCT Omeza Products Used in Combination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2022-07-11 |
| Est. Completion | 2024-05-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05921292
The ClinicalTrials.gov registry entry for NCT05921292 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Omeza, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omeza Products Used in Combination is the first listed.
NCT05921292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05921292 about?
NCT05921292 is a clinical study titled "Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies". The goal of this clinical trial is to evaluate the use of Omeza combination therapy with Standard of Care. The main question it aims to answer is: \- Can Omeza combination therapy with Standard of Care enable chronic wounds to begin a healing trajectory in a 4-week period? Patients will be treated...
What is the current status of trial NCT05921292?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 111 participants. The study started on 2022-07-11. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05921292?
The interventions under investigation include: Omeza Products Used in Combination (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05921292?
This trial is sponsored by Omeza, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.